 |
Sharp fall in late trading pulled the indices to the low of the day on June 14 with Nifty ended below 11,850 level.
At close, the Sensex was down 289.29 points at 39,452.07, while Nifty was down 90.70 points at 11,823.30. About 808 shares have advanced, 1686 shares declined, and 144 shares are unchanged.
IndusInd Bank, Zee Entertainment, Indiabulls Housing, Bharti Airtel and Axis Bank were the top losers on the Nifty, while gainers were Bharti Infratel, Sun Pharma, Power Grid, L&T and Vedanta.
All the sectoral indices ended lower led by FMCG, bank, auto, pharma, infra, metal, IT and energy.
HEADLINES OF THE DAY
At close, the Sensex was down 289.29 points at 39,452.07, while Nifty was down 90.70 points at 11,823.30. About 808 shares have advanced, 1686 shares declined, and 144 shares are unchanged.
IndusInd Bank, Zee Entertainment, Indiabulls Housing, Bharti Airtel and Axis Bank were the top losers on the Nifty, while gainers were Bharti Infratel, Sun Pharma, Power Grid, L&T and Vedanta.
All the sectoral indices ended lower led by FMCG, bank, auto, pharma, infra, metal, IT and energy.
HEADLINES OF THE DAY
Biocon biologics facilities receive EU GMP certification: Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Substance (DS) facilities at Biocon Park, Bengaluru.
Aurobindo Pharma shares fell 5 percent on June 14 after the US health regulator pointed out data integrity lapses at finished dosages plant in Bachupally, Telangana.
Kalpataru Power Transmission shares gained 1.7 percent intraday after global brokerage house PhillipCapital India initiated coverage with a buy rating and target price of Rs 670, implying 37 percent potential upside.
Adani Gas shares rallied 6.8 percent after a media report indicated that French energy giant Total SA is close to acquiring a 30 percent stake in Indian gas distribution company.
Sun Pharmaceutical Industries announced interim results from a Phase 2 study of interleukin-23 (IL-23) inhibitor ILUMYATM in patients with active psoriatic arthritis that was presented in a late-breaking oral presentation at the Annual European Congress of Rheumatology in Madrid, Spain.
The crucial resistance for Nifty spot is now seen at 11960 and above this 12080 Support for the immediate term is now placed at 11660 next support will be 11520.
No comments:
Post a Comment